Coverage with timely administered vaccination against hepatitis b virus and its influence on the prevalence of HBV infection in the regions of different endemicity

  • Karen K. Kyuregyan (Corresponding Author)
  • , Vera S. Kichatova
  • , Olga V. Isaeva
  • , Ilya A. Potemkin
  • , Elena Yu Malinnikova
  • , Maria A. Lopatukhina
  • , Anastasia A. Karlsen
  • , Fedor A.Asadi Mobarhan
  • , Eugeniy V. Mullin
  • , Olga S. Slukinova
  • , Margarita E. Ignateva
  • , Snezhana S. Sleptsova
  • , Elena E. Oglezneva
  • , Elena V. Shibrik
  • , Maria G. Isaguliants
  • , Mikhail I. Mikhailov

    Research output: Contribution to journalArticlepeer-review

    15 Citations (Scopus)
    84 Downloads (Pure)

    Abstract

    Universal hepatitis B vaccination of newborns was implemented in Russia starting from 1998. From 1998 to 2019, the incidence of acute hepatitis B reduced from 43.8 to 0.57 cases per 100,000 population. Here, we assessed the timely coverage of newborns with the birth dose (HepB-BD), second dose (HepB-2nd), and three vaccine doses (HepB3) in two remote regions of Russia with low (Belgorod Oblast) and high (Yakutia) levels of hepatitis B virus (HBV) endemicity. Vaccination data were obtained from the medical records of 1000 children in Yakutia and 2182 children in Belgorod Oblast. Sera of healthy volunteers from Belgorod Oblast (n = 1754) and Yakutia (n = 1072) across all age groups were tested for serological markers of HBV to assess the infection prevalence and herd immunity. Average HepB-BD coverage was 99.2% in Yakutia and 89.4% in Belgorod Oblast (p < 0.0001) and in both regions varied significantly, from 66% to 100%, between medical centers. The principal reason for the absence of HepB-BD was parent refusal, which accounted for 63.5% of cases of non-vaccination (83/123). While timely HepB-2nd coverage was only 55.4%–64.7%: HepB3 coverage by the age of one year exceeded 90% in both study regions. HBV surface antigen (HBsAg) prevalence in the 1998–2019 birth cohort was 0.2% (95% CI: 0.01–1.3%) in Belgorod Oblast and 3.2% (95% CI: 1.9–5.2%) in Yakutia. The proportion of persons testing negative for both antibodies to HBsAg (anti-HBs) and antibodies to HBV core antigen (anti-HBc) in the 1998–2019 birth cohort was 26.2% (125/481) in Belgorod Oblast and 32.3% (162/501) in Yakutia. We also assessed the knowledge of and attitude towards vaccination among 782 students and teachers of both medical and non-medical specialties from Belgorod State University. Only 60% of medical students knew that hepatitis B is a vaccine-preventable disease. Both medical and nonmedical students, 37.8% and 31.3%, respectively, expressed concerns about safety and actual necessity of vaccination. These data indicate the need to introduce a vaccine delivery audit system, improve medical education with respect to vaccination strategies and policies, and reinforce public knowledge on the benefits of vaccination.

    Original languageEnglish
    Article number82
    Pages (from-to)1-15
    Number of pages15
    JournalVaccines
    Volume9
    Issue number2
    DOIs
    Publication statusPublished - 23 Jan 2021

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords*

    • Birth dose coverage
    • HBV prevalence
    • Hepatitis B epidemiology
    • Hepatitis B vaccine
    • Public health

    Field of Science*

    • 3.1 Basic medicine

    Publication Type*

    • 1.1. Scientific article indexed in Web of Science and/or Scopus database

    Fingerprint

    Dive into the research topics of 'Coverage with timely administered vaccination against hepatitis b virus and its influence on the prevalence of HBV infection in the regions of different endemicity'. Together they form a unique fingerprint.

    Cite this